이연제약
102460KOSPI의약품 제조업37.0 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
Il Yeon Pharm is a specialized pharmaceutical company established in 1964, focusing on the manufacturing and sales of prescription drugs, original pharmaceuticals (e.g., CT contrast agent 'Optirey'), and bulk drugs. Its Chungju facility, certified for biopharmaceutical production and CMO services, supports new drug pipeline development through a production-platform-based R&D model. However, as of 2024, the company reported sales of 145.9 billion won, an operating loss of 30.3 billion won, and a net loss of 29.6 billion won, indicating the need for improved profitability.
Number of Employees
457people
Average Salary
76.4M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
Well below industry avg
3.8x industry avg (risky)
Avg ▼1.7% (2-year basis)
Avg ▼19193.7% (2-year basis)
Avg ROE -3.2% (declining, 3yr)
Detailed News Sentiment
Detailed Momentum
Near 52w low (0%, downtrend)
1m -5.71% (slight drop)
Volume flat
Detailed Disclosure
- Neutral정기주주총회결과2026-03-30
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-30
- Neutral사업보고서 (2025.12)2026-03-20
- Neutral감사보고서제출2026-03-20
